Cited 7 times since 2012 (0.6 per year) source: EuropePMC Clinical pharmacology and therapeutics, Volume 93, Issue 3, 12 2 2012, Pages 233 Doubt about the feasibility of preemptive genotyping. Koch BC, van Schaik RH, van Gelder T, Mathijssen RH, Rotterdam Clinical Pharmacology-Pharmacogenetics Group (RCPPG)